Mangoceuticals inc MGRX.US 總覽分析
MGRX 投資分析
看多重點：
- 價值≥4
- 股利≥2
分析結論
公司發布財報數據季度不足，尚無法提供評分
MGRX 近期報酬表現
4.35%
Mangoceuticals inc
3.56%
同產業平均
1.47%
S&P500
與 MGRX 同產業的標的表現
- DRUG Bright minds biosciences inc價值 2 分趨勢 2 分波段 2 分籌碼 -股利 1 分查看更多
MGRX 公司資訊
Mangoceuticals, Inc. is primarily focused on developing, marketing, and selling a variety of men's health and wellness products and services via a secure telemedicine platform. The Company has developed and is commercially marketing a new brand of erectile dysfunction (ED) products under the brand name Mango and a brand of hair loss products under the brand name Grow. These products are produced at a compounding pharmacy using a proprietary combination of United States Food and Drug Administration (FDA) approved ingredients and are available to patients on the determination of a prescribing physician that the compounded drug is necessary for the individual patient. It is marketing and selling these branded ED and hair loss products exclusively online via its Website at www.MangoRx.com. Its customer platform connects consumers to licensed healthcare professionals through its Website for the provision of care via telehealth. It also owns a global patent portfolio of oral solution.